Opto Circuits arm gets Brazilian FDA nod

Opto Circuits India (OCI), the Bangalore-based manufacturer of medical diagnostics and interventional products, today announced that its California-based international marketing arm, Mediaid Inc., has received Brazilian FDA agency - Agencia Nacional de Vigilancia Sanitaria (ANVISA) - approval for marketing and sale of the Mediaid brand of US FDA-approved Pulse Oximetry (SPO2) products (Patient Monitors & Sensors) in the country and surrounding geographies.

Jayesh Patel, director, OCI, said: “Brazil is the largest medical device market in Latin America and an access into the country’s healthcare industry will help enhance peripheral geography sales too. Growth in Brazil’s private health insurance and a hospital modernisation drive by the government along with a strong consumer demand for latest technologies will drive further growth. We are confident of using the present opportunities to grow our market share in the geography.”

Pulse oximetry (detection of arterial oxygen saturation and heartbeat rate) is one of the five ‘vital signs’ that are monitored on a patient. Continuous oxygenation monitoring in hospitals and other critical care settings is now a standard of care.

Mediaid products that will be sold in Brazil are: Model M30, M34, M900, M960 and variants thereof, the company said in a statement.